Skip to main content
ARS Home » Research » Publications at this Location » Publication #188213
Title: DEVELOPMENTAL TOXICITY OF FUSARIUM VERTICILLIOIDES AND FUMONISIN B1 IN LM/BC AND CD1 MICE: COMPARING THE IN VIVO MODELS

Author
item Voss, Kenneth
item Riley, Ronald
item BURNS, TANTIANA - TOX., UGA, ATHENS
item GELINEAU-VAN WAES, JANEE - U.NEB.MED.CEN., OMAHA, NE

Submitted to: Aflatoxin Elimination Workshop Proceedings
Publication Type: Abstract Only
Publication Acceptance Date: 10/5/2005
Publication Date: 7/1/2006
Citation: Voss, K.A., Riley, R.T., Burns, T.D., Gelineau-Van Waes, J.B. 2005. Developmental toxicity of fusarium verticillioides and fumonisin b1 in lm/bc and cd1 mice: comparing the in vivo models. Proceeding of the 2005 Annual MultiCrop Aflatoxin/Fumonisin Elimination and Fungal Genomics Workshop. Raleigh, North Carolina. p. 63.

Interpretive Summary: Abstract - no summary.

Technical Abstract: The human health effects of Fusarium verticillioides and fumonisins are uncertain. There is evidence however suggesting that fumonisins disrupt folate utilization and increase the risk of neural tube defects (NTDs = birth defects cause by failure of the neural tube to close properly) in populations that depend heavily on fumonisin-contaminated corn as a food source. Fumonisin B1 (FB1) was not teratogenic when given orally (gavage) to pregnant CD1 mice on gestation days (GD) 7-15 whereas intraperitoneal (ip) injection of > 5 mg/kg BW FB1 on GD7 and GD8, the critical time for neural tube closure, to pregnant LM/Bc mice caused NTDs. Experiments were therefore done to compare the incidence of NTDs in litters of LM/Bc and CD1 dams given FB1 by two different dosing protocols: (a) dietary exposure to fumonisins (provided by adding F. verticillioides culture material to the diet) beginning 5 weeks before mating and (b) ip administration of FB1 on GD7 and GD8. The results of the feeding studies were inconclusive. Diets containing 50 ppm FB1 did not cause NTDs in either strain. At the maternally toxic dose of 150 ppm FB1, one of five LM/Bc litters was NTD positive (1/10 fetuses affected) whereas fetal death rates were higher but no NTDs were found in the CD1 strain (n=9 litters). In a second feeding trial using LM/Bc mice, NTDs were not found in the fetuses of females fed diets containing 150 or 300 ppm FB1. A dose-related increase in NTDs was found in the litters of CD1 dams (n=8-10/dose level) given FB1 by ip injection on GD7 and GD8: 0, 11, 0, and 40 percent of the litters were NTD positive at doses of 0, 15, 30 and 45 mg/kg BW FB1, respectively. This result was confirmed in a second experiment. NTDs were found in 0, 8.3, 16.6, 36.4, 54.5 percent of the litters of CD1 dams (n=8-12/dose level) given 0, 10, 23, 45 or 100 mg FB/kg BWt FB1 ip on GD7 and GD8. In affected litters of dams given < 45 ppm FB1, 33 percent or less of the CD1 fetuses had NTDs. The number of NTD positive fetuses from affected litters of CD1 dams given 100 mg/kg BWt FB1 tended to be higher: 15 to 100 percent exhibited NTD (average mean for the group = 42 percent). In contrast, 100 percent of the litters and > 50 percent of the fetuses from LM/Bc dams given > 15 mg/kg FB1 by this ip dosing schedule were NTD positive. These results indicate that (a) both mouse strain and dosing regimen affect NTD induction; (b) induction of NTDs by ip FB1 exposure during the critical time for neural tube closure is not unique to the LM/Bc mouse strain; (c) LM/Bc mice are more sensitive to NTD induction than CD1 mice; and (d) unequivocal induction of NTDs by dietary exposure to fumonisins remains to be shown. Comparative studies using fumonisin-exposed LM/Bc and CD1 mice will be useful for elucidating the physiological and biochemical events involved in NTD formation in vivo.